BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 29674419)

  • 1. Comparison of the RGD Motif-Containing α
    Roesch S; Lindner T; Sauter M; Loktev A; Flechsig P; Müller M; Mier W; Warta R; Dyckhoff G; Herold-Mende C; Haberkorn U; Altmann A
    J Nucl Med; 2018 Nov; 59(11):1679-1685. PubMed ID: 29674419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET/CT Imaging of NSCLC with a α
    Flechsig P; Lindner T; Loktev A; Roesch S; Mier W; Sauter M; Meister M; Herold-Mende C; Haberkorn U; Altmann A
    Mol Imaging Biol; 2019 Oct; 21(5):973-983. PubMed ID: 30671741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a Novel ITGα
    Altmann A; Sauter M; Roesch S; Mier W; Warta R; Debus J; Dyckhoff G; Herold-Mende C; Haberkorn U
    Clin Cancer Res; 2017 Aug; 23(15):4170-4180. PubMed ID: 28468949
    [No Abstract]   [Full Text] [Related]  

  • 4. Preclinical evaluation of peptide-based radiotracers for integrin αvβ6-positive pancreatic carcinoma.
    Müller M; Altmann A; Sauter M; Lindner T; Jäger D; Rathke H; Herold-Mende C; Marmé F; Babich J; Mier W; Haberkorn U
    Nuklearmedizin; 2019 Aug; 58(4):309-318. PubMed ID: 31075798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of a peptide with affinity to head and neck cancer.
    Nothelfer EM; Zitzmann-Kolbe S; Garcia-Boy R; Krämer S; Herold-Mende C; Altmann A; Eisenhut M; Mier W; Haberkorn U
    J Nucl Med; 2009 Mar; 50(3):426-34. PubMed ID: 19223422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET/CT imaging of head-and-neck and pancreatic cancer in humans by targeting the "Cancer Integrin" αvβ6 with Ga-68-Trivehexin.
    Quigley NG; Steiger K; Hoberück S; Czech N; Zierke MA; Kossatz S; Pretze M; Richter F; Weichert W; Pox C; Kotzerke J; Notni J
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1136-1147. PubMed ID: 34559266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Translation of a
    Feng X; Wang Y; Lu D; Xu X; Zhou X; Zhang H; Zhang T; Zhu H; Yang Z; Wang F; Li N; Liu Z
    J Nucl Med; 2020 Oct; 61(10):1461-1467. PubMed ID: 32086242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical Evaluation of
    Ganguly T; Bauer N; Davis RA; Foster CC; Harris RE; Hausner SH; Roncali E; Tang SY; Sutcliffe JL
    J Nucl Med; 2023 Apr; 64(4):639-644. PubMed ID: 36207137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a peptide derived from foot-and-mouth disease virus for the noninvasive imaging of human cancer: generation and evaluation of 4-[18F]fluorobenzoyl A20FMDV2 for in vivo imaging of integrin alphavbeta6 expression with positron emission tomography.
    Hausner SH; DiCara D; Marik J; Marshall JF; Sutcliffe JL
    Cancer Res; 2007 Aug; 67(16):7833-40. PubMed ID: 17699789
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Ren J; Zhu S; Zhang G; Tan X; Qiu L; Lin J; Jiang L
    Mol Pharm; 2022 Jul; 19(7):2620-2628. PubMed ID: 35674464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Copper-64-Labeled α
    Ganguly T; Bauer N; Davis RA; Hausner SH; Tang SY; Sutcliffe JL
    Mol Pharm; 2021 Dec; 18(12):4437-4447. PubMed ID: 34783573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-fluorobenzoate-labeled cystine knot peptides for PET imaging of integrin αvβ6.
    Hackel BJ; Kimura RH; Miao Z; Liu H; Sathirachinda A; Cheng Z; Chin FT; Gambhir SS
    J Nucl Med; 2013 Jul; 54(7):1101-5. PubMed ID: 23670900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging integrin αvβ3 on blood vessels with 111In-RGD2 in head and neck tumor xenografts.
    Terry SY; Abiraj K; Frielink C; van Dijk LK; Bussink J; Oyen WJ; Boerman OC
    J Nucl Med; 2014 Feb; 55(2):281-6. PubMed ID: 24408894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of an Integrin α
    Gai Y; Jiang Y; Long Y; Sun L; Liu Q; Qin C; Zhang Y; Zeng D; Lan X
    Mol Pharm; 2020 Jan; 17(1):349-358. PubMed ID: 31829615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vivo PET Imaging of the Cancer Integrin αvβ6 Using
    Notni J; Reich D; Maltsev OV; Kapp TG; Steiger K; Hoffmann F; Esposito I; Weichert W; Kessler H; Wester HJ
    J Nucl Med; 2017 Apr; 58(4):671-677. PubMed ID: 27980050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiogallium Complex-Conjugated Bifunctional Peptides for Detecting Primary Cancer and Bone Metastases Simultaneously.
    Ogawa K; Yu J; Ishizaki A; Yokokawa M; Kitamura M; Kitamura Y; Shiba K; Odani A
    Bioconjug Chem; 2015 Aug; 26(8):1561-70. PubMed ID: 26087328
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Fan D; Zhang C; Luo Q; Li B; Ai L; Li D; Jia W
    Front Oncol; 2023; 13():1070967. PubMed ID: 36968997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and characterization of a
    Ui T; Ueda M; Higaki Y; Kamino S; Sano K; Kimura H; Saji H; Enomoto S
    Bioorg Med Chem; 2020 Jan; 28(1):115189. PubMed ID: 31740201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effects of an Albumin Binding Moiety on the Targeting and Pharmacokinetics of an Integrin α
    Hausner SH; Bauer N; Davis RA; Ganguly T; Tang SYC; Sutcliffe JL
    Mol Imaging Biol; 2020 Dec; 22(6):1543-1552. PubMed ID: 32383076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.